Regulus Therapeutics Inc.·4

Aug 14, 4:34 PM ET

Rosen Hugh 4

4 · Regulus Therapeutics Inc. · Filed Aug 14, 2023

Insider Transaction Report

Form 4
Period: 2023-08-10
Rosen Hugh
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-10+15,00015,000 total
    Exercise: $1.36Exp: 2033-08-09Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The options will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant, subject to the Reporting Person's continuous service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION